Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors (Journal article)

Simitsopoulou, M./ Roilides, E./ Paliogianni, F./ Likartsis, C./ Ioannidis, J./ Kanellou, K./ Walsh, T. J.

Voriconazole (VRC) has activity against Aspergillus fumigatus, the most frequent cause of invasive aspergillosis in immunocompromised patients. The combination of VRC and A. fumigatus hyphae induced a more pronounced profile of expression of genes encoding inflammatory molecules in human monocytes than Aspergillus alone did. Herein, we provide further evidence of the potential mechanism underlying this immunomodulatory effect of VRC on human monocytes in response to A. fumigatus hyphae. A significant additive antifungal effect was shown when VRC was combined with monocytes against A. fumigatus hyphae. Both A. fumigatus hyphae and VRC induced pronounced profiles of mRNA and protein expression of Toll-like receptor 2 (TLR2) as well as tumor necrosis factor alpha (TNF-alpha) in THP-1 monocytic cells compared to untreated cells. The VRC-induced increase was greater than that induced by hyphae. The combination of VRC and hyphae increased mRNA and protein expression of TLR2 and TNF-alpha to even higher levels than did either VRC or hyphae alone. In contrast, TLR4 expression, both at the mRNA and protein levels, was not increased by either VRC or hyphae or their combination. In addition, significantly more NF-kappaB was translocated to the nuclei of THP-1 cells treated with VRC than untreated cells. While VRC induced more NF-kappaB than hyphae did, treatment with the combination of the two factors induced the greatest NF-kappaB expression. The pronounced profile of TLR2 signaling, TNF-alpha expression, and NF-kappaB activation in the presence of VRC suggests an immunomodulatory effect leading to a more efficient response to A. fumigatus.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antifungal Agents/*pharmacology,Aspergillus fumigatus/growth & development/immunology/*pathogenicity,Cell Line,Cells, Cultured,*Gene Expression Regulation,Humans,Hyphae/immunology,*Monocytes/drug effects/immunology/metabolism/microbiology,NF-kappa B/genetics/metabolism,Pyrimidines/*pharmacology,RNA, Messenger/genetics/metabolism,Toll-Like Receptor 2/genetics/metabolism,Toll-Like Receptors/genetics/*metabolism,Triazoles/*pharmacology,Tumor Necrosis Factor-alpha/genetics/metabolism
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20958
ISSN: 1098-6596
Link: http://www.ncbi.nlm.nih.gov/pubmed/18625774
http://aac.asm.org/content/52/9/3301.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Simitsopoulou-2008-Immunomodulatory eff.pdf303.64 kBAdobe PDFView/Open


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20958
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.